The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Risk factors for cholangiocarcinoma
Open accessAbstract
Cholangiocarcinoma (CC) is the second most common primary hepatic malignancy after hepatocellular cancer. CC accounts for approximately 10%-25% of all hepatobiliary malignancies. There are considerable geographic and demographic variations in the incidence of CC. There are several established risk factors for CC, including parasitic infections, primary sclerosing cholangitis, biliary-duct cysts, hepatolithiasis, and toxins. Other less-established potential risk factors include inflammatory bowel disease, hepatitis C virus, hepatitis B virus, cirrhosis, diabetes, obesity, alcohol drinking, tobacco smoking, and host genetic polymorphisms. In studies where the distinction between intra- and extrahepatic CC was used, some potential risk factors seem to have a differential effect on CC, depending on the site. Therefore, the consistent use of a more refined classification would allow a better understanding of risk factors for CC. (HEPATOLOGY 2011;)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epidemiology of Cholangiocarcinoma
Shaib, Y., & El-Serag, H. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828889 · Cited by 1,132
Self-citationIncreasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.25087 · Cited by 1,010
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Burak, K., Angulo, P., Pasha, T. M., Egan, K., Petz, J., & Lindor, K. D. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04067.x · Cited by 557
Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
Shaib, Y. H., El-Serag, H. B., Davila, J. A., Morgan, R., & McGlynn, K. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.048 · Cited by 546
Self-citationCholangiocarcinoma: lessons from Thailand
Sripa, B., & Pairojkul, C. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282fbf9b3 · Cited by 531
Welzel, T. M., Graubard, B. I., El–Serag, H. B., Shaib, Y. H., Hsing, A. W., Davila, J. A., & McGlynn, K. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.020 · Cited by 514
Self-citationWorldwide trends in mortality from biliary tract malignancies
Patel, T. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-10 · Cited by 491
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
Khan, S. A., Toledano, M. B., & Taylor-Robinson, S. D. (2008) · HPB · doi:10.1080/13651820801992641 · Cited by 431
High lifetime risk of cancer in primary sclerosing cholangitis
Claessen, M. M. H., Vleggaar, F. P., Tytgat, K. M. A. J., Siersema, P. D., & van Buuren, H. R. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.013 · Cited by 412
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998
Taylor-Robinson, S. D., Toledano, M. B., Arora, S., Keegan, T. J., Hargreaves, S., Beck, A., Khan, S. A., Elliott, P., & Thomas, H. C. (2001) · Gut · doi:10.1136/gut.48.6.816 · Cited by 381
Welzel, T. M., McGlynn, K. A., Hsing, A. W., O'Brien, T. R., & Pfeiffer, R. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj234 · Cited by 372
Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
Chalasani, N., Baluyut, A., Ismail, A., Zaman, A., Sood, G., Ghalib, R., McCashland, T. M., Reddy, R. K., Zervos, X., Anbari, M. A., et al. (2000) · Hepatology · doi:10.1002/hep.510310103 · Cited by 336
Sørensen, H. T., Friis, S., Olsen, J. H., Thulstrup, A. M., Mellemkjær, L., Linet, M., Trichopoulos, D., Vilstrup, H., & Olsen, J. (1998) · Hepatology · doi:10.1002/hep.510280404 · Cited by 328
El‐Serag, H. B., Engels, E. A., Landgren, O., Chiao, E., Henderson, L., Amaratunge, H. C., & Giordano, T. P. (2009) · Hepatology · doi:10.1002/hep.22606 · Cited by 313
Self-citationCholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation
Boberg, K. M., Bergquist, A., Mitchell, S., Pares, A., Rosina, F., Broomé, U., Chapman, R., Fausa, O., Egeland, T., Rocca, G., et al. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202760373434 · Cited by 311
Bergquist, A., Glaumann, H., Persson, B., & Broomé, U. (1998) · Hepatology · doi:10.1002/hep.510270201 · Cited by 281
Shaib, Y. H., El-Serag, H. B., Nooka, A. K., Thomas, M., Brown, T. D., Patt, Y. Z., & Hassan, M. M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01104.x · Cited by 258
Self-citationPrimary sclerosing cholangitis: Summary of a workshop
LaRusso, N. F., Shneider, B. L., Black, D., Gores, G. J., James, S. P., Doo, E., & Hoofnagle, J. H. (2006) · Hepatology · doi:10.1002/hep.21337 · Cited by 251
Donato, F., Gelatti, U., Tagger, A., Favret, M., Ribero, M. L., Callea, F., Martelli, C., Savio, A., Trevisi, P., & Nardi, G. (2001) · Cancer Causes & Control · doi:10.1023/a:1013747228572 · Cited by 247
SHIN, H.-R., LEE, C.-U., PARK, H.-J., SEOL, S.-Y., CHUNG, J.-M., CHOI, H.-C., AHN, Y.-O., & SHIGEMASTU, T. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.5.933 · Cited by 237
Patel, T. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0389 · Cited by 224
Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study
Lee, T. Y., Lee, S. S., Jung, S. W., Jeon, S. H., Yun, S.-C., Oh, H.-C., Kwon, S., Lee, S. K., Seo, D. W., Kim, M.-H., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01796.x · Cited by 217
Blechacz, B. R. A., & Gores, G. J. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.003 · Cited by 212
Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden†
Lindkvist, B., Benito de Valle, M., Gullberg, B., & Björnsson, E. (2010) · Hepatology · doi:10.1002/hep.23678 · Cited by 206
Welzel, T. M., Mellemkjaer, L., Gloria, G., Sakoda, L. C., Hsing, A. W., Ghormli, L. E., Olsen, J. H., & McGlynn, K. A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22283 · Cited by 195
Söreide, K., Körner, H., Havnen, J., & Söreide, J. A. (2004) · British Journal of Surgery · doi:10.1002/bjs.4815 · Cited by 193
Liver cancer in Thailand. I. A case‐control study of cholangiocarcinoma
Parkin, D. M., Srivatanakul, P., Khlat, M., Chenvidhya, D., Chotiwan, P., Insiripong, S., L'abbé, K. A., & Wild, C. P. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480302 · Cited by 191
Cholangiocarcinoma: Update and future perspectives
Gatto, M., Bragazzi, M. C., Semeraro, R., Napoli, C., Gentile, R., Torrice, A., Gaudio, E., & Alvaro, D. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.12.008 · Cited by 188
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
Yamamoto, S., Kubo, S., Hai, S., Uenishi, T., Yamamoto, T., Shuto, T., Takemura, S., Tanaka, H., Yamazaki, O., Hirohashi, K., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02492.x · Cited by 187
Honjo, S., Srivatanakul, P., Sriplung, H., Kikukawa, H., Hanai, S., Uchida, K., Todoroki, T., Jedpiyawongse, A., Kittiwatanachot, P., Sripa, B., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21146 · Cited by 180
Hepatolithiasis associated with cholangiocarcinoma
Kubo, S., Kinoshita, H., Hirohashi, K., & Hamda, H. (1995) · World Journal of Surgery · doi:10.1007/bf00294744 · Cited by 177
Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China
Zhou, Y.-M., Yin, Z.-F., Yang, J.-M., Li, B., Shao, W.-Y., Xu, F., Wang, Y.-L., & Li, D.-Q. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.632 · Cited by 171
Opisthorchis viverrini: The carcinogenic human liver fluke
Kaewpitoon, N. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.666 · Cited by 166
Incidence and mortality of primary sclerosing cholangitis in the UK: A population-based cohort study
Card, T. R., Solaymani–Dodaran, M., & West, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.017 · Cited by 147
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms
Melum, E., Karlsen, T. H., Schrumpf, E., Bergquist, A. M., Thorsby, E., Boberg, K. M., & Lie, B. A. (2007) · Hepatology · doi:10.1002/hep.21964 · Cited by 134
Kornfeld, D., Ekbom, A., & Ihre, T. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011222 · Cited by 132
Descriptive Epidemiology of Cholangiocarcinoma and Clonorchiasis in Korea
Shin, H., Oh, J., Lim, M. K., Shin, A., Kong, H., Jung, K., Won, Y., Park, S., Park, S., & Hong, S. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.7.1011 · Cited by 122
Polymorphism of glutathione S-transferase Omega gene and risk of cancer
Marahatta, S. B., Punyarit, P., Bhudisawasdi, V., Paupairoj, A., Wongkham, S., & Petmitr, S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.020 · Cited by 113
Thorotrast-Induced Liver Neoplasia: A Collective Review
Lipshutz, G. S., Brennan, T. V., & Warren, R. S. (2002) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(02)01287-5 · Cited by 95
The antecedents of biliary cancer: a primary care case–control study in the United Kingdom
Grainge, M. J., West, J., Solaymani–Dodaran, M., Aithal, G. P., & Card, T. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604765 · Cited by 94
Sakoda, L. C., Gao, Y.-T., Chen, B. E., Chen, J., Rosenberg, P. S., Rashid, A., Deng, J., Shen, M.-C., Wang, B.-S., Han, T., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi314 · Cited by 70
Erichsen, R., Jepsen, P., Vilstrup, H., Ekbom, A., & Sørensen, H. T. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9365-4 · Cited by 69
Marital status and stage at diagnosis of cutaneous melanoma
McLaughlin, J. M., Fisher, J. L., & Paskett, E. D. (2010) · Cancer · doi:10.1002/cncr.25726 · Cited by 64
Relation of hepatolithiasis to helminthic infestation
Huang, M., CHEN, C., Yen, C., Yang, J.-C., Yang, C., Yeh, Y., Chou, D., Yueh, S.-K., YANG, Y., & Nien, C. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03523.x · Cited by 57
Bile Duct Dysplasia in the Setting of Chronic Hepatitis C and Alcohol Cirrhosis
Torbenson, M. S., Yeh, M. M., & Abraham, S. C. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318053d122 · Cited by 53
Huang, W., Gao, Y.-T., Rashid, A., Sakoda, L. C., Deng, J., Shen, M.-C., Wang, B., Han, T.-Q., Zhang, B.-H., Chen, B. E., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm247 · Cited by 48
Prawan, A., Kukongviriyapan, V., Tassaneeyakul, W., Pairojkul, C., & Bhudhisawasdi, V. (2005) · European Journal of Cancer Prevention · doi:10.1097/00008469-200506000-00008 · Cited by 43
Increased risk of death in thorotrast-exposed patients during the late follow-up period.
Kato, I., & Kido, C. (1987) · PubMed · Cited by 42
Höblinger, A., Grünhage, F., Sauerbruch, T., & Lammert, F. (2009) · Digestion · doi:10.1159/000212990 · Cited by 37
Songsivilai, S., Dharakul, T., & Kanistanon, D. (1996) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(96)90296-5 · Cited by 27
Cited by
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Razumilava, N., & Gores, G. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61903-0 · Cited by 1,729
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Ilyas, S. I., & Gores, G. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.013 · Cited by 1,307
Metadata
- Authors
- Tyson, G. L., & El-Serag, H. B.
- Venue
- Hepatology
- Published
- 2011-07
- Volume
- 54
- Issue
- 1
- Pages
- 173-184
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2123767664
- Cited by
- 956
- References
- 50
- FWCI
- 47.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.